The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
The promoter polymorphism -1562C/T in matrix metalloproteinase-9 and COPD severity Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006
The promoter polymorphism -1562C/T in matrix metalloproteinase-9 and COPD severity Source: Eur Respir Rev 2006; 15: 230-232 Year: 2006
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Effects of glutation-S-transferase M1 (GSTM1) and T1 (GSTT1) and matrix metalloproteinase 9 (MMP9) on the decline of lung function in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004
Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Matrix Metalloproteinases (MMPs) in patients with pulmonary tuberculosis (PT) and comorbid COPD Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
Matrix remodeling in IPF: the important role of MMPs-1, -2, -9 and TIMP-1, TIM-2 Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
Matrix metalloproteinase 2 expression in distal lung of fatal asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD) Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Correlation between a polymorphism in the promotor region of MMP3 (Stromelisyn-1) and the clinical-functional history in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007